摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Methyl-4-chlorstyrol | 121135-78-2

中文名称
——
中文别名
——
英文名称
2-Methyl-4-chlorstyrol
英文别名
2-Methyl-4-chlorostyrene;4-chloro-1-ethenyl-2-methylbenzene
2-Methyl-4-chlorstyrol化学式
CAS
121135-78-2
化学式
C9H9Cl
mdl
——
分子量
152.623
InChiKey
BPVVTRJJQZINNG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

反应信息

  • 作为反应物:
    描述:
    2-Methyl-4-chlorstyrol 在 dimethyl sulfide borane 、 三乙胺 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 6.5h, 生成
    参考文献:
    名称:
    [EN] HISTONE DEMETHYLASE INHIBITORS
    [FR] INHIBITEURS D'HISTONES DÉMÉTHYLASES
    摘要:
    这份披露涉及抑制组蛋白去甲基化酶活性的化合物。具体而言,该披露涉及抑制组蛋白赖氨酸去甲基化酶KDM5B的化合物,以及使用这些化合物和药物组合物的方法,例如使用本文披露的化合物和药物组合物治疗癌症的方法。
    公开号:
    WO2017143011A1
点击查看最新优质反应信息

文献信息

  • New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
    申请人:Boehringer Ingelheim International GmbH
    公开号:US20040242572A1
    公开(公告)日:2004-12-02
    The present invention relates to carboxamide compounds of general formula I 1 wherein the groups and residues A, B, W, X, Y, Z, R 1 , R 2 , R 3 and k have the meanings given in claim 1. Moreover the invention relates to process for preparing the above mentioned carboxamides as well as pharmaceutical compositions containing at least one carboxamide according to the invention. In view of their MCH-receptor antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia and diabetes.
    本发明涉及具有通式I的羧酰胺化合物 1 其中,A、B、W、X、Y、Z、R 1 、R 2 、R 3 和k的含义如权利要求1中所述。此外,本发明还涉及制备上述羧酰胺的方法以及含有至少一种根据本发明的羧酰胺的药物组合物。由于它们对MCH受体的拮抗活性,根据本发明的药物组合物适合用于治疗代谢紊乱和/或饮食紊乱,特别是肥胖症、厌食症、暴食症、糖尿病。
  • Transparent polycarbonate polyester composition and process
    申请人:——
    公开号:US20040097662A1
    公开(公告)日:2004-05-20
    Disclosed is a transparent/translucent molding composition and process for making prepared from an impact modifier and a resin blend of polycarbonate and a cycloaliphatic polyester having a matching index of refraction.
    公开了一种透明/半透明的模塑组合物和制备过程,该组合物由冲击改性剂和聚碳酸酯和环状脂肪族聚酯的树脂混合物制成,具有匹配的折射率指数。
  • 3-Imidazolyl-Indoles for the Treatment of Proliferative Diseases
    申请人:Boettcher Andreas
    公开号:US20100125064A1
    公开(公告)日:2010-05-20
    The invention relates to 3-heterocyclyl indolyl compounds capable of inhibiting the interaction between p53, or variants thereof, and MDM2 and/or MDM4, or variants thereof, respectively, said compounds having the formula I, wherein R 1 , R 2 , R 3 , R 4 , R A , Y and Y are as defined in the specification. Due to their activity, the compounds are useful in the treatment of various disorders and diseases mediated by the activity of MDM2 and/or MDM4, or variants thereof, such as inflammatory or proliferative diseases or in the protection of cells.
    本发明涉及能够抑制p53或其变体与MDM2和/或MDM4或其变体相互作用的3-杂环基吲哚化合物,其中所述化合物具有式I,其中R1、R2、R3、R4、RA、Y和Y的定义见说明书。由于其活性,这些化合物可用于治疗由MDM2和/或MDM4或其变体介导的各种疾病和疾病,例如炎症性或增殖性疾病或细胞保护。
  • Transparent Polycarbonate Polyester Composition and Process
    申请人:Gaggar Satish Kumar
    公开号:US20110086951A1
    公开(公告)日:2011-04-14
    Disclosed is a transparent/translucent molding composition and process for making prepared from an impact modifier and a resin blend of polycarbonate and a cycloaliphatic polyester having a matching index of refraction.
    本发明涉及一种透明/半透明的模塑组合物和制备方法,该组合物由冲击改性剂和聚碳酸酯和环状脂肪族聚酯的树脂混合物制成,其具有匹配的折射率指数。
  • MODIFIED CARBON BLACK AND PREPARATION METHOD THEREFOR
    申请人:ZHANG Yigang
    公开号:US20160251519A1
    公开(公告)日:2016-09-01
    The present invention provides a modified carbon black, with an unsaturated coupling agent being grafted on the surface thereof. An unsaturated double bond on one end of the coupling agent is grafted on the surface of the carbon black to serves as a grafting group; and an active group on the other end serves as a crosslink group to retain a crosslinking function with rubber in the future. At least one coupling agent is selected from sulfur-containing compound, halogen-containing compound, nitrogen-containing compound, polyunsaturated compound. The present invention also provides an energy ball milling preparation method for the described product, and provides the formulas and preparation method of two kinds of sulfur-containing unsaturated coupling agent i.e., thioether and thiuram compounds for the described product. The modified carbon black could be crosslinked together with tire rubber. If the carbon black does not move, the rubber also does not move, thereby improving wet grip and driving safety. If the rubber moves, the carbon black also move, thereby reducing internal friction and saving oil, and reducing heat generated from the tire and prolonging the service life of the tire.
    本发明提供了一种改性碳黑,其表面接枝有不饱和偶联剂偶联剂一端的不饱和双键被接枝在碳黑表面上,作为接枝基团;另一端的活性基团作为交联基团,将来与橡胶保持交联功能。至少选择一种偶联剂,包括含硫化合物含卤化合物含氮化合物、多不饱和化合物。本发明还提供了所述产品的能量球磨制备方法,并提供了两种含不饱和偶联剂醚和硫脲化合物的配方和制备方法。改性碳黑可以与轮胎橡胶交联。如果碳黑不动,橡胶也不动,从而提高湿地抓地力和行车安全性。如果橡胶移动,碳黑也移动,从而减少内部摩擦和节省油耗,减少轮胎产生的热量并延长轮胎使用寿命。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫